Table 1.
Baseline characteristics of patients with Graves’ disease
| Parameter | thymic hyperplasia | No-thymic hyperplasia | P Value |
|---|---|---|---|
| (n = 19) | (n = 77) | ||
| Age(year) | 42.6±11.3 | 51.6±15.0 | 0.018 |
| Gender | 0.564 | ||
| Male | 7(36.8%) | 34(44.2%) | |
| Female | 12(63.2%) | 43(55.8%) | |
| Ca (mmol/L) | 2.40±0.13 | 2.30±0.11 | 0.001 |
| ALP (IU/L) | 108.78±36.50 | 92.05±36.30 | 0.076 |
| TRAb(IU/L) | 10.23 (3.99-18.74) | 7.70 (3.39-18.80) | 0.499 |
| TSH(mIU/L) | 0.000 (0.000-0.001) | 0.000 (0.000-0.001) | 0.689 |
| FT3(pmol/L) | 18.66 (9.58-47.00) | 16.21 (9.73-22.91) | 0.492 |
| FT4(pmol/L) | 28.88 (20.12-40.02) | 29.58 (24.90-40.32) | 0.547 |
Ca Calcium, ALP Alkaline phosphatase, FT3 Free triiodothyronine, FT4 Free thyroxine, TSH Thyrotropin, TRAb Thyrotrophin receptor antibodies